denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
Program: Scientific Workshops
Session: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
Friday, December 8, 2023, 3:29 PM-4:14 PM
Disclosures: Starczynowski: Sumitomo Pharma Oncology: Research Funding; Captor Therapeutics: Consultancy; Kurome Therapeutics: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties, Research Funding; Treeline Biosciences: Research Funding; Tolero Therapeutics: Research Funding; Kymera Therapeutics: Consultancy.
See more of: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>